Despite the end of the pandemic, coronavirus disease 2019 (COVID-19) remains a major
public health concern. The first waves of the virus led to a better understanding of its …

COVID‐19, which was first identified in 2019 in Wuhan, China, is a respiratory illness
caused by a virus called severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) …

Hyperactivation of pro-inflammatory type 1 cytokines (eg, tumor necrosis factor alpha [TNF-α]
and interferon gamma [IFN-γ]) mirrors the inflammation of coronavirus disease 2019 …

Platelets are central elements of hemostasis and also play a pivotal role in the pathogenesis
of thrombosis in coronavirus disease 2019. This study was planned to investigate the effects …

In addition to the respiratory symptoms associated with COVID-19, the disease has
consistently been linked to many autoimmune diseases such as systemic lupus …

We believe there are serious problems with a recently published and highly publicized
paper entitled “Serotonin reduction in post-acute sequelae of viral infection.” The blood …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the
respiratory distress condition known as COVID-19. This disease broadly affects several …

Background The relaxation of the “zero-COVID” policy on Dec. 7, 2022, in China posed a
major public health threat recently. Complete blood count test was discovered to have …

Purpose This study assessed medication patterns for inpatients at a central hospital in
Portugal and explored their relationships with clinical outcomes in COVID-19 cases …

Patients with COVID-19 have coagulation and platelet disorders, with platelet alterations
and thrombocytopenia representing negative prognostic parameters associated with severe …